[e-drug] Banning metamisole in Moldova (9)

[Sukkari, Sana <ssukkari@jbmh.com>]

E-drug: Banning metamisole in Moldova (9)
------------------------------------------------------------


Dear Natalia,

The following reference has some relevant information related to 
metamisole:
Hargis JB, La Russa VF, Redmond J, Kessler SW, Wright DG. 
Agranulocytosis associated with "Mexican aspirin" (dipyrone): 
evidence for an autoimmune mechanism affecting multipotential 
hematopoietic progenitors. Am J Hematol. 1989 Jul;31(3):213-5. 

Dipyrone is reported to be the most common drug sold to Mexican 
immigrants by illegal back room shops in California near the US.-
Mexican border.  The drug was withdrawn from the U.S. market in 
1977 but still in the Mexican market place.  Perhaps someone in the 
Mexican regulatory authorities is waiting for the Mexican adverse 
drug reaction report data to exist and a satisfactory number of death 
and harm accumulate then act to take the drug off the market.


Sana R. Sukkari, B.Sc.Pharm., M.Phil.
Oncology/Palliative Care Pharmacist
Joseph Brant Memorial Hospital
1230 North Shore Blvd.
Burlington, Ontario
L7R 4C4
e-mail: ssukkari@jbmh.com
Tel: (905) 632 3737 ext.: 5636
Fax: (905) 336 6492


--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: owner-e-drug@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html